UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) Director Stephen J. Hemsley sold 99,312 shares of the company’s stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the transaction, the director now owns 787,372 shares of the company’s stock, valued at approximately $420,669,238.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
UnitedHealth Group Trading Up 1.3 %
Shares of UnitedHealth Group stock opened at $541.49 on Friday. The firm’s 50-day moving average price is $501.67 and its two-hundred day moving average price is $496.57. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The company has a quick ratio of 0.78, a current ratio of 0.77 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $508.01 billion, a price-to-earnings ratio of 28.28, a PEG ratio of 1.64 and a beta of 0.77.
UnitedHealth Group (NYSE:UNH – Get Rating) last posted its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. During the same period last year, the company posted $4.70 EPS. The firm’s quarterly revenue was up 12.6% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Incorporated will post 21.84 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on UNH. Argus upped their price target on shares of UnitedHealth Group from $580.00 to $650.00 and gave the company a “buy” rating in a report on Monday. Cowen increased their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Cowen increased their target price on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Raymond James upped their price target on shares of UnitedHealth Group from $540.00 to $620.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, April 19th. Finally, StockNews.com started coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Three analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $582.50.
Institutional Investors Weigh In On UnitedHealth Group
Several hedge funds have recently added to or reduced their stakes in UNH. WBH Advisory Inc. bought a new position in UnitedHealth Group during the 4th quarter worth approximately $258,000. Taylor Wealth Management Partners raised its holdings in UnitedHealth Group by 30.7% during the 4th quarter. Taylor Wealth Management Partners now owns 1,044 shares of the healthcare conglomerate’s stock worth $524,000 after purchasing an additional 245 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $346,859,000. Wayfinding Financial LLC bought a new position in UnitedHealth Group during the 4th quarter worth approximately $217,000. Finally, Arcus Capital Partners LLC raised its holdings in UnitedHealth Group by 95.9% during the 4th quarter. Arcus Capital Partners LLC now owns 2,173 shares of the healthcare conglomerate’s stock worth $1,091,000 after purchasing an additional 1,064 shares during the last quarter. 87.48% of the stock is currently owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Was The Market Wrong On Etsy Again, As Shares Gain Post Earnings?
- Is Google The Buy Of The Summer?
- Should CVS Health Be in Your Portfolio?
- Wingstop And Hershey Are Two Food Stocks Overcoming Inflation
- Can International Business Machines Recover After Its Sell-Off?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.